XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Fair Values Of Financial Instruments  
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

Assets and liabilities measured at fair value are summarized below:

 

   Total Fair Value   Quoted Prices
in Active Markets
for Identical
Assets/Liabilities (Level 1)
  

Significant Other
Observable Inputs

(Level 2)

  

Significant
Unobservable
Inputs

(Level 3)

 
Assets:                    
                     
Recurring items as of December 31, 2022                           
Corporate debt securities, available for sale  $21,254,485   $   $        $21,254,485 
                     
Non-recurring items as of December 31, 2022                    
In-process R&D (Note 6)  $   $   $   $ 
                     
Recurring items as of December 31, 2021                    
Corporate debt securities and U.S. treasury obligations, available for sale  $29,803,095   $   $   $29,803,095 
                     
Non-recurring items as of December 31, 2021                    
In-process R&D (Note 6)  $13,366,234   $   $   $13,366,234 
                     
Liabilities:                    
                     
Recurring items as of December 31, 2022                    
Earn-out milestone liability (Note 13)  $   $   $   $ 
                     
Recurring items as of December 31, 2021                    
Earn-out milestone liability (Note 13)  $5,396,000   $   $   $5,396,000